Condition: Psychotic Episode · Sponsor: Centre Hospitalier Universitaire de Saint Etienne
The First-Episode Psychosis (FPE) is a severe disorder that can include delusions, cognitive disorders and suicidal behavior. In the majority of cases (more than 80%) it evolves into schizophrenia. Numerous studies show that the rapidity of the initial management of FPE would reduce the risk of negative evolution and would have a decisive impact on the short and long term prognosis. The rapidity of this management can be measured by the duration of untreated psychosis, or DUP (Duration of Untreated Psychosis), the time interval between the appearance of the first frank psychotic symptoms and the initiation of adequate psychiatric care. The objective of this study is to show the impact of an intervention facilitating access to specialized care for PEP on the reduction of DUP. This intervention consists of an early identification program for FPE, the PRESTO program, specifically targeting 3 determining steps in the reduction of DUP: * Informing the general population about psychotic disorders * Knowledge of front line actors (APL: general practitioners, school and university medicine, teenager's house, associative networks educators, emergency services, firefighters, etc.) about FPE and its management * Articulation between APL and specialized psychiatric care
This description comes directly from the study's public registry record.
Eric FAKRA, MD PhD · (0)477127885 · eric.fakra@chu-st-etienne.fr
Amandine BAUDOT, CRA · (0)477829450 · amandine.baudot@chu-st-etienne.fr
Always discuss trial participation with your own doctor first.
| Hospices Civils de Lyon | Bron, France | Recruiting |
| Chu Clermont-Ferrand | Clermont-Ferrand, France | Recruiting |
| Chu Grenoble | Grenoble, France | Recruiting |
| CHU de Montpellier | Montpellier, France | Recruiting |
| CHU de Nîmes | Nîmes, France | Recruiting |
| Chu Saint Etienne | Saint-Etienne, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05813457